ArticleBiometrical journal. Biometrische Zeitschrift2026
Optimal Designs for Identifying Effective Doses in Drug Combination Studies.
Article in Biometrical journal. Biometrische Zeitschrift, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimal Designs for Identifying Effective Doses in Drug Combination Studies.Biometrical journal. Biometrische Zeitschrift · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
We consider the optimal design problem for identifying effective dose combinations within drug combination studies where the effect of the combination of two drugs is investigated. Drug combination studies are becoming increasingly important as they investigate potential interaction effects rather than the individual impacts of the drugs. In this situation, identifying effective dose combinations that yield a prespecified effect is of special interest. If nonlinear surface models are used to describe the dose combination-response relationship, these effective dose combinations, also called isoboles, result in specific contour lines of the fitted response model. Consequently, accurately estimating these effective dose combinations is crucial. We propose a novel design criterion that targets the precise estimation of these effective dose combinations. In particular, an optimal design minimizes the width of the confidence band of the contour lines of interest. Optimal design theory is developed for this problem, including equivalence theorems and efficiency bounds. The performance of the optimal design is illustrated in different examples modeling dose combination data by various nonlinear surface models. It is demonstrated that the proposed optimal design for identifying effective dose combinations yields a more precise estimation of the effective dose combinations than ray or factorial designs, which are commonly used in practice. This particularly holds true for a case study motivated by data from an oncological dose combination study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.